{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Dabhel, Daman",
      "state": "",
      "country": "India",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "97766",
      "recalling_firm": "USV Private Limited",
      "address_1": "H-13, 16, 16a, 17, 18, 19, 20, 21 & E-22, Oidc, Mahatma Gandhi Udyog Nagar",
      "address_2": "",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide within the United States",
      "recall_number": "D-0034-2026",
      "product_description": "Olopatadine Hydrochloride Ophthalmic Solution USP 0.1 %, 5 mL (0.17 FL OZ) bottles, Manufactured for: SOLA PHARMACEUTICALS LLC, Baton Rouge, LA 70810, NDC 70512-0520-05",
      "product_quantity": "8,952 bottles",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: The result for 'Any individual unspecified impurity' exceeds the specification limit.",
      "recall_initiation_date": "20251009",
      "center_classification_date": "20251020",
      "report_date": "20251029",
      "code_info": "Lot #:  35000409, Exp. Date 01/2026",
      "more_code_info": ""
    }
  ]
}